Key Success Factors for Unearthing the Promise of Biospecimen Research

Add bookmark

Key Success Factors for Unearthing the Promise of Biospecimen Research

Add bookmark

Lisa Miranda, President and CEO, Biobusiness Consulting, Inc., Vice President, Strategic Alliances and International Biobank Relations, Trans-Hit Biomarkers Inc., and Senior Advisor, Business Development, Bluechiip Ltd. joins Amber Scorah from Pharma IQ, to share her insights and thoughts on what she coins to be the "Age of Utilisation, Collaboration and Innovation" along with an overview of some of the key success factors for unearthing the promise of biospecimen research.

[inlinead]
 


Upcoming Events

DigIT Pharma 2026 | AI Commercial, Medical & Patient Care

September 9 - 10, 2026

Steigenberger Airport Hotel Berlin, Deutschland

DigIT Pharma 2026 | AI Commercial, Medical & Patient Care

Pharmaceutical Launch Excellence Summit US

September 30 - October 1 2026

Hyatt Regency Boston Harbor, Boston, US

Pharmaceutical Launch Excellence Summit US

SmartLab Exchange Europe

22 - 23 February 2027

Leonardo Royal Hotel Amsterdam, Netherlands

SmartLab Exchange Europe

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended